Represented Kimberly Clark Corporation (NYSE: KMB) in connection with its $4 billion five-year revolving credit agreement and $1.8 billion delayed draw term loan credit agreement, $3.8 billion of which will be available to fund the previously announced acquisition of Kenvue Inc. (NYSE: KVUE)
Represented CoreWeave (Nasdaq: CRWV) in the amendment and upsize of its $2.5 billion debt financing facility
Represented Kimberly-Clark Corp. (Nasdaq: KMB) in its pending $48.7 billion acquisition of Kenvue (NYSE: KVUE), a global consumer health company
